A Study of XZP-3287 in Combination With Fulvestrant in Patients With Advanced Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Advanced Breast Cancer
Related studies linked through entity extraction aliases.
IMM2902, a HER2/SIRPα Bispecific MAb-Trap Antibody-receptor Fusion Protein, in Patients with HER2-expressing Advanced Solid Tumors
- Status
- SUSPENDED
- Phase
- PHASE1
Trastuzumab + Alpelisib +/- Fulvestrant vs Trastuzumab + CT in Patients With PIK3CA Mutated Previously Treated HER2+ Advanced BrEasT Cancer (ALPHABET)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Study of Chidamide Combined With Fulvestrant in the Treatment of Hormone Receptor-positive Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- NA
Screening Plasma HER2 Amplication by Digital PCR in Advanced Breast Cancer Patients Treated With Trastuzumab and Pyrotinib
- Status
- UNKNOWN
- Phase
- PHASE2
Patritumab Deruxtecan (U3-1402) in Unresectable Locally Advanced or Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
PFMT Educational Intervention for Patients With Advancer Breast Cancer
- Status
- UNKNOWN
- Phase
- NA
A Study in Patients With Advanced Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Study of MRG002 in the Treatment of Patients With HER2-positive Unresectable Locally Advanced or Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA Suppression
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Talazoparib in Advanced Breast Cancer Patients With Homologous Recombinant Deficiency
- Status
- RECRUITING
- Phase
- PHASE2
Pilot Decentralized Clinical Trial in Men and Pre and Post-menopausal Women With Breast Cancer and a Specific Mutation (PIK3CA) Treated With Alpelisib in Combination With Fulvestrant
- Status
- TERMINATED
- Phase
- PHASE2
Study of CYH33 in Combination With Endocrine Therapy With or Without Palbociclib in Patients With HR+, HER2- Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
POL6326 (Balixafortide) Plus Nab-paclitaxel or Eribulin in Patients With HER2-negative Advanced Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of SHR6390 Combined With Famitinib in the Treatment of HR + / HER2- Advanced Breast Cancer.
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Irinotecan Liposome Injection in Patients With Advanced Breast Cance
- Status
- COMPLETED
- Phase
- PHASE1
CB-103 Plus NSAI In Luminal Advanced Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Pilot Study of a Micro-Organosphere Drug Screen Platform to Lead Care in Advanced Breast Cancer
- Status
- TERMINATED
- Phase
- N/A
Omic Technologies to Track Resistance to Palbociclib in Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA